Sg3 Management, LLC Adma Biologics, Inc. Transaction History

Sg3 Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.28 - $1.83 $94,720 - $135,420	-74,000 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$1.09 - $1.66 $74,229 - $113,046	68,100 Added 1154.24%	74,000 $104,000
Q3 2021 Nov 15, 2021	SELL	$1.13 - $1.65 $61,132 - $89,265	-54,100 Reduced 90.17%	5,900 $7,000
Q1 2021 May 17, 2021	BUY	$1.67 - $2.95 $100,200 - $177,000	60,000 New	60,000 $106,000

319

185M

917K

91.6K

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $4.29B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.